Table 3.
Study Design | Results | Reference |
---|---|---|
Male patients with McArdle’s disease; BCAAs or BCKAs prior to start cycling exercise. | After BCAAs: deterioration of exercise performance and ↑ in ammonia. After BCKAs: improved exercise performance and smaller ↑ in ammonia. |
[24] |
Rats; AA+KAEAAs (0.3 g/kg) or saline orally 1 h before exercise. | Attenuated increase in ammonia; ↓ urea. | [75] |
Cyclists; ketogenic diet for 2 days before experiment, AA+KAEAAs or lactose orally 1 h before cycling (2 h). | Attenuated increase in ammonia induced by exercise. | [76] |
Male untrained volunteers; α-KG or BCKAs (0.2 g/kg/d) for 4 weeks during endurance training (running). | α-KG or BCKAs improved training effects and recovery state. | [77] |
Patients with type 2 diabetes; training on cycle ergometer and mixture of α-KG and BCKAs (0.2 g/kg orally) for 6 weeks or placebo (glucose, sodium and calcium salts). | Positive effects on physical training (higher VO2max, endurance capacity, and power output). | [78] |
Cyclists; ketogenic diet for 2 days before experiment, AA+KAEAAs or lactose, cycling session (2 h) followed by a maximum test. | ↑ (~70%) ammonia in placebo, not in AA+KAEAAs group. No difference in physical or cognitive performance. | [79] |
Cyclists, ketogenic diet for 2 days before experiment, AA+KAEAAs or lactose orally 1 h before cycling (2 h). | ↑ ammonia, creatine kinase, lactate dehydrogenase, and AST in placebo group. No significant changes in AA+KAAAs group. | [80] |
AA + KAEAAs, mixture of amino acids and ketoanalogues of essential amino acids.